Brokerages expect Quaker Chemical Co. (NYSE:KWR) to post $208.35 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Quaker Chemical’s earnings, with the highest sales estimate coming in at $214.00 million and the lowest estimate coming in at $202.70 million. Quaker Chemical posted sales of $194.91 million during the same quarter last year, which suggests a positive year-over-year growth rate of 6.9%. The company is scheduled to report its next earnings report after the market closes on Monday, April 30th.
On average, analysts expect that Quaker Chemical will report full-year sales of $1.30 billion for the current year, with estimates ranging from $1.26 billion to $1.34 billion. For the next year, analysts expect that the business will report sales of $1.68 billion per share, with estimates ranging from $1.66 billion to $1.70 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Quaker Chemical.
Quaker Chemical (NYSE:KWR) last announced its quarterly earnings data on Wednesday, February 28th. The specialty chemicals company reported $1.27 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.26 by $0.01. The firm had revenue of $211.10 million during the quarter, compared to analyst estimates of $208.07 million. Quaker Chemical had a return on equity of 15.48% and a net margin of 2.47%. Quaker Chemical’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.26 earnings per share.
In other Quaker Chemical news, Director Adrian Steeples sold 1,957 shares of Quaker Chemical stock in a transaction that occurred on Tuesday, March 6th. The stock was sold at an average price of $150.34, for a total value of $294,215.38. Following the completion of the transaction, the director now directly owns 5,101 shares in the company, valued at $766,884.34. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Michael F. Barry sold 1,250 shares of Quaker Chemical stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $160.13, for a total value of $200,162.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 9,186 shares of company stock valued at $1,399,442. 3.20% of the stock is currently owned by insiders.
A number of hedge funds have recently modified their holdings of the business. BlackRock Inc. boosted its stake in Quaker Chemical by 3.2% in the fourth quarter. BlackRock Inc. now owns 1,646,283 shares of the specialty chemicals company’s stock valued at $248,242,000 after acquiring an additional 50,506 shares during the period. Carillon Tower Advisers Inc. acquired a new position in Quaker Chemical in the fourth quarter valued at approximately $103,056,000. Goldman Sachs Group Inc. boosted its stake in Quaker Chemical by 7.7% in the fourth quarter. Goldman Sachs Group Inc. now owns 279,860 shares of the specialty chemicals company’s stock valued at $42,200,000 after acquiring an additional 20,012 shares during the period. Ranger Investment Management L.P. boosted its stake in Quaker Chemical by 141.2% in the fourth quarter. Ranger Investment Management L.P. now owns 214,455 shares of the specialty chemicals company’s stock valued at $32,338,000 after acquiring an additional 125,543 shares during the period. Finally, GW&K Investment Management LLC boosted its stake in Quaker Chemical by 1.7% in the fourth quarter. GW&K Investment Management LLC now owns 117,249 shares of the specialty chemicals company’s stock valued at $17,680,000 after acquiring an additional 2,002 shares during the period. Institutional investors own 92.16% of the company’s stock.
Quaker Chemical stock traded down $0.63 during midday trading on Monday, hitting $153.23. The stock had a trading volume of 33,393 shares, compared to its average volume of 48,746. The company has a quick ratio of 2.06, a current ratio of 2.63 and a debt-to-equity ratio of 0.15. The firm has a market cap of $2,047.41, a P/E ratio of 30.58, a P/E/G ratio of 2.48 and a beta of 1.30. Quaker Chemical has a 12 month low of $129.98 and a 12 month high of $165.93.
The business also recently announced a quarterly dividend, which will be paid on Monday, April 30th. Shareholders of record on Monday, April 16th will be paid a $0.355 dividend. The ex-dividend date is Friday, April 13th. This represents a $1.42 dividend on an annualized basis and a yield of 0.93%. Quaker Chemical’s payout ratio is currently 28.34%.
ILLEGAL ACTIVITY NOTICE: “$208.35 Million in Sales Expected for Quaker Chemical Co. (KWR) This Quarter” was published by WKRB News and is the sole property of of WKRB News. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.wkrb13.com/2018/04/22/208-35-million-in-sales-expected-for-quaker-chemical-co-kwr-this-quarter.html.
About Quaker Chemical
Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. Its products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.